| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |